Source: European journal of clinical pharmacology. Unidade: FM
Subjects: POLIMORFISMO, ANTICOAGULANTES, ALGORITMOS GENÉTICOS, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVARES, Leticia C. et al. Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population. European journal of clinical pharmacology, v. 74, n. 12, p. 1555-1566, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00228-018-2528-z. Acesso em: 08 maio 2024.APA
Tavares, L. C., Duarte, N. E., Marcatto, L. R., Soares, R. A. G., Krieger, J. E., Pereira, A. C., & Santos, P. C. J. L. (2018). Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population. European journal of clinical pharmacology, 74( 12), 1555-1566. doi:10.1007/s00228-018-2528-zNLM
Tavares LC, Duarte NE, Marcatto LR, Soares RAG, Krieger JE, Pereira AC, Santos PCJL. Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population [Internet]. European journal of clinical pharmacology. 2018 ; 74( 12): 1555-1566.[citado 2024 maio 08 ] Available from: https://doi.org/10.1007/s00228-018-2528-zVancouver
Tavares LC, Duarte NE, Marcatto LR, Soares RAG, Krieger JE, Pereira AC, Santos PCJL. Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population [Internet]. European journal of clinical pharmacology. 2018 ; 74( 12): 1555-1566.[citado 2024 maio 08 ] Available from: https://doi.org/10.1007/s00228-018-2528-z
